However, for visceral fat specifically, tesamorelin shows the most dramatic reduction in the deep abdominal compartment
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Among commercially insured non-diabetic individuals with obesity, people who identified as female, received point-of-service or preferred provider organization insurance coverage, and who took medications such as antidepressants or thyroid or hormone medications, were more likely to begin taking semaglutide compared to people who identified as males, or those who were covered by health management organization or exclusive provider organization plans
doi:10.1093/humupd/dmz019
Semaglutide is contraindicated in patients with: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Common Adverse Effects According to clinical trial data, gastrointestinal effects are most frequently reported: nausea, vomiting, diarrhea, constipation, and abdominal discomfort
Expect defendants to argue the clock started at first diagnosis, hospitalization, or when you were told the likely cause